Lung Cancer News

The FDA granted orphan drug designation to HSB-1216 for the treatment of small cell lung cancer, according to the agent’s manufacturer.

Occupational exposure to carcinogens often is overshadowed by smoking as a risk factor for lung cancer, yet it has been linked to an estimated 30% of lung cancers. Moreover, those who experience this exposure, including first responders, frequently are missed by lung cancer screening guidelines from the U.S. Preventive Services Task Force.

As 2019 comes to a close, the Healio Pulmonology Editors have compiled a list of the most-read articles published this year.

GO2 Foundation for Lung Cancer announced the recipients of its 2019 Young Innovators Team Awards.

Healio Pulmonology has you covered. The Editors have compiled a list of popular articles posted on Healio Pulmonology in November.

The FDA granted priority review to a supplemental biologics license application that seeks approval of durvalumab for previously untreated extensive-stage small cell lung cancer.

International Association for the Study of Lung Cancer appointed Chandra P. Belani, MD, as its new chief science officer.

A new study has identified nine specific causes of death that are related to exposure to ambient fine particulate matter air pollution.

Brigatinib conferred a durable PFS benefit compared with crizotinib among patients with ALK-positive non-small cell lung cancer who had not received prior ALK inhibitor therapy, according to updated results of the phase 3 ALTA-1L trial presented at ESMO Asia.

This year’s CHEST Annual Meeting, held from Oct. 19 to 23 in New Orleans, highlighted important research and issues in pulmonary, critical care and sleep medicine.